Skip to main content

Table 5 Characteristics at baseline before PSM: sample of dizziness or vertigo, with the complication of cerebral infarction

From: Clinical and economic analysis of Gastrodin injection for dizziness or vertigo: a retrospective cohort study based on electronic health records in China

Variable

Total (N = 1042)

Gastrodin injection (N = 727)

Extract of Ginkgo Biloba Leaves injection (N = 315)

P

Region, (n, %)

   

 < 0.001

 Eastern

427 (41.0)

323 (44.4)

104 (33.0)

 

 Central

305 (29.3)

136 (18.7)

169 (53.7)

 

 Western

228 (21.9)

205 (28.2)

23 (7.3)

 

 Northeast

82 (7.9)

63 (8.7)

19 (6.0)

 

Hospital level, (n, %)

   

0.001

 Tertiary

983 (94.3)

677 (93.1)

306 (97.1)

 

 Secondary

32 (3.1)

31 (4.3)

1 (0.3)

 

 Primary

27 (2.6)

19 (2.6)

8 (2.5)

 

Hospital department, (n, %)

   

0.064

 Neurology

776 (74.5)

541 (74.4)

235 (74.6)

 

 E.N.T

18 (1.7)

0

0

 

 Cardiovascular medicine

1 (0.1)

17 (2.3)

1 (0.3)

 

 ICU

247 (23.7)

1 (0.1)

0 (0.0)

 

 Others

64 (56, 69)

168 (23.1)

79 (25.1)

 

Age (y), (n, %)

   

0.022

 [18, 45]

35 (3.4)

19 (2.6)

16 (5.1)

 

 [45,60]

314 (30.1)

230 (31.6)

84 (26.7)

 

 [60,75]

657 (63.1)

448 (61.6)

209 (66.3)

 

 ≥ 75

36 (3.5)

30 (4.1)

6 (1.9)

 

Gender (n, %)

   

0.281

 Female

510 (48.9)

364 (50.1)

146 (46.3)

 

 Male

532 (51.1)

363 (49.9)

169 (53.7)

Â